Frank Meiss Selected Research

Frank Meiss Research Topics

Disease

38	Melanoma (Melanoma, Malignant) 05/2024 - 05/2012
22	Neoplasms (Cancer) 01/2024 - 05/2012
9	Skin Neoplasms (Skin Cancer) 05/2023 - 01/2018
9	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2019
5	Brain Neoplasms (Brain Tumor) 01/2023 - 04/2016
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 01/2018
2	Disease Progression 06/2023 - 04/2016
2	Ulcer 01/2018 - 03/2006
2	Fatigue 11/2014 - 09/2013
1	Epidermolysis Bullosa 01/2024
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 06/2023
1	Carcinoma (Carcinomatosis) 06/2023
1	Hepatitis 12/2022
1	ST Elevation Myocardial Infarction 08/2022
1	Infarction (Infarctions) 08/2022
1	Vasculitis (Vasculitides) 08/2022
1	Atrial Fibrillation 08/2022
1	Bullous Pemphigoid (Pemphigoid) 01/2022
1	Pigmented Nevus (Melanocytic Nevus) 01/2022
1	Melanosis (Freckles) 01/2022
1	Skin Manifestations 01/2021
1	Colitis 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Hypothyroidism 12/2018
1	Inflammation (Inflammations) 01/2018
1	Pancreatitis 01/2018
1	Crohn Disease (Crohn's Disease) 01/2018
1	Sarcoidosis (Schaumann Disease) 01/2018
1	Ulcerative Colitis 01/2018
1	Thyroiditis 01/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2014
1	Pain (Aches) 08/2009
1	Postherpetic Neuralgia 08/2009
1	Cancer Pain 08/2009

Drug/Important Bio-Agent (IBA)

11	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2024 - 11/2014
11	Immune Checkpoint InhibitorsIBA 05/2024 - 09/2019
7	IpilimumabIBA 01/2022 - 05/2012
5	Biomarkers (Surrogate Marker)IBA 06/2023 - 01/2018
4	NivolumabIBA 05/2023 - 12/2018
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 04/2016
4	trametinibIBA 01/2022 - 01/2018
3	VemurafenibIBA 01/2018 - 11/2014
2	EnzymesIBA 01/2024 - 01/2018
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 06/2023 - 01/2018
2	AntibodiesIBA 05/2023 - 01/2018
2	pembrolizumabIBA 05/2023 - 01/2022
2	Interleukin-2 (IL2)IBA 01/2022 - 09/2019
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2018
2	Circulating Tumor DNAIBA 11/2020 - 08/2020
2	VitaminsIBA 01/2017 - 03/2006
2	InterferonsIBA 01/2017 - 11/2014
1	Immune Checkpoint ProteinsIBA 01/2024
1	LigandsIBA 06/2023
1	Apoptosis Regulatory ProteinsIBA 06/2023
1	cyclopropapyrroloindoleIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 12/2022
1	Immunoglobulin G (IgG)IBA 12/2022
1	Amiodarone (Amiodarona)FDA LinkGeneric 08/2022
1	Clopidogrel (Plavix)FDA Link 08/2022
1	Codon (Codons)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 01/2022
1	MethyltransferasesIBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	ChemokinesIBA 09/2020
1	Differentiation AntigensIBA 09/2020
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2020
1	Immunomodulating AgentsIBA 09/2019
1	talimogene laherparepvecIBA 09/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	HhAntag691IBA 01/2018
1	cobimetinibIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Everolimus FDA Link 01/2018
1	Collagen Type XVIIIBA 01/2018
1	BiglycanIBA 06/2017
1	Trace Elements (Biometals)IBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Phosphotransferases (Kinase)IBA 11/2014
1	tyrosine receptor (receptor, tyrosine)IBA 11/2014
1	SDMIBA 02/2014
1	Interferon-alpha (Interferon Alfa)IBA 09/2013
1	CytokinesIBA 05/2012
1	Blocking AntibodiesIBA 05/2012
1	Opioid Analgesics (Opioids)IBA 08/2009
1	Local AnestheticsIBA 08/2009
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2009

Therapy/Procedure

29	Therapeutics 05/2024 - 03/2006
8	Immunotherapy 01/2024 - 05/2012
4	Radiotherapy 01/2022 - 01/2017
3	Complementary Therapies (Alternative Medicine) 01/2017 - 05/2016
1	Investigational Therapies (Experimental Therapy) 01/2022
1	Plasmapheresis 01/2021
1	Photopheresis 01/2020
1	Injections 09/2019
1	Heart Transplantation (Grafting, Heart) 01/2018
1	Drug Therapy (Chemotherapy) 01/2017
1	Cell Transplantation 05/2012